Updates are available Correction dated 2017-02-09
Click to view Correction: https://doi.org/10.1038/nrdp.2017.8
-
Authors
Kipps, Thomas J.
Stevenson, Freda K.
Wu, Catherine J.
Croce, Carlo M.
Packham, Graham
Wierda, William G.
O'Brien, Susan
Gribben, John
Rai, Kanti
- License Information
-
More Information
Article History
First Online: 19 January 2017
Competing interests
: J.G. has received honoraria for advisory boards from Roche, Genentech, AbbVie, Janssen, Pharmacyclics, Acerta, Gilead, TG Therapeutics and Unum. S.O. has acted as a consultant for Amgen and Celgene, is a scientific advisory board member for CLL Global Research Foundation and has received research support from Acerta, TG Therapeutics, Regeneron, Gilead, Pharmacyclics and ProNAi. K.R. is a member of the medical advisory board for Celgene, Roche/Genetech, Pharmacyclics and Gilead. T.J.K. has received honoraria for Ad boards, meetings, presentations and/or consulting from Gilead, Pharmacyclics, Celgene, Roche and AbbVie, and has received research funding from AbbVie and Celgene. C.J.W. is a co-founder and a member of the scientific advisory board of Neon Therapeutics. W.G.W., G.P., C.M.C. and F.K.S. declare no competing interests.
